Literature DB >> 828444

Treatment of lupus nephritis.

V E Pollak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 828444

Source DB:  PubMed          Journal:  Adv Nephrol Necker Hosp        ISSN： 0084-5957


× No keyword cloud information.
  5 in total

Review 1.  Systemic lupus erythematosus: treatment and prognosis.

Authors:  G R Hughes
Journal:  Br Med J       Date:  1979-10-27

2.  Effect of cyclophosphamide on glomerular permeability and localization of immunoreactants in NZB/NZW mice.

Authors:  O I Czechner; T Cavallo
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

3.  Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.

Authors:  P Appleby; D G Webber; J G Bowen
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

4.  Murine lupus nephritis: effects of cyclophosphamide on circulating and tissue bound immunoreactants.

Authors:  T Cavallo; K Graves; N A Granholm
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

5.  Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.

Authors:  H C Gunn
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.